Mode
Text Size
Log in / Sign up
Phase 4 N=21 Randomized Single-blind Treatment

Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques

Carotid Artery Stenosis

Enrolled (actual)
21
Serious AEs
4.8%
Results posted
Apr 2022
Primary outcome: Primary: Time to First Neurological Exam — 9; 7; 7 Minutes

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Remifentanil, Propofol, and Desflurane (Drug); Remifentanil, Dexmedetomidine, and Desflurane (Drug); Remifentanil and Desflurane (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The Cooper Health System
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to First Neurological Exam
9; 7; 7

Summary

The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid endarterectomy. Carotid endarterectomy surgery removes the plaque and stenosis but has a 1-3% risk of periprocedural stroke or death. The ability to detect neurological abnormalities early after surgery is vital in this patient population to facilitate timely additional diagnostics or interventions if a potential stroke is detected. Anesthetic techniques that facilitate an earlier reliable neurological exam will thus greatly benefit this surgical patient population. The primary objective of this pilot study is to determine the time difference from end of surgery to first neurologic exam between three commonly used anesthetic methods for carotid endareterectomy.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Having carotid endarterectomy surgery
  • Able to undergo a preoperative neurological exam

Exclusion Criteria

  • Pregnant patients
  • Prisoners
  • Patients with dementia or reduced mental status acute or chronic
  • Known brain tumor or head trauma
  • Known severe, uncorrected coronary artery disease (CAD)
  • Ejection fraction (EF) less than 15%
  • Patients with intraaortic ballon pump (IABP) or other mechanical circulatory assist device
  • Patients with severe chronic obstructive pulmonary disease (COPD)
  • Combined surgical procedures (CABG and CAD)
  • Patients with uncontrolled or severe anxiety requiring benzodiazepine administration
  • Patients with history of difficult airway
  • Sedation other than propofol, dexmedetomidine or volatile anesthetic agent (VAA) is needed for patient (i.e. ketamine in patients with history of neuropathic pain)
  • Intubated or unconscious patients
  • Patients on methadone or fentanyl patch
  • Patients with known unusual or extreme anesthetic requirements
  • Patients who would require an unusual amount of narcotic to control pain
  • Patients having endarterectomy wherein surgeon requests local-regional anesthesia only
  • Patients with known history of prolonged emergence from anesthesia
  • Morbidly obese patients (BMI >40)
  • Patients with scalp or forehead defects that prohibit application of BIS monitor strip
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03996148). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search